(Reuters) - South Carolina's Supreme Court ordered Johnson & Johnson to pay a penalty of $136 million, upholding a jury's finding that the drugmaker's Janssen unit had improperly marketed its anti-psychotic drug Risperdal and concealed its risks.
A trial court had earlier ordered J&J to pay $327 million, but the Supreme Court more than halved that penalty, citing a provision in South Carolina law that no action can be taken in such cases after three years of the discovery of unlawful conduct. South Carolina filed its complaint in April 2007.
22:16 GOP files federal appeal but Mich. recount continues11
20:16 Trump supporters aggressively challenge Stein recount efforts in three states18
03:00 Carrier incentives stir debate over 'rewarding' offshoring15
18:07 Trump’s deal to keep Carrier jobs in Indiana includes $7 million in state subsidies15